AzTrials
AzTrials

FibromyalgiaNCT03588208

Progressive Resistance Training for Fibromyalgia

A study testing Progressive resistance training program and Educational Program in people with Fibromyalgia, run by Federal University of São Paulo.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients in the experimental group underwent a progressive resistance training program, performed twice a week for 12 weeks. The charge intensity was progressively increased from 40% to 80% of 1 repetition maximum. Read more about this study

Who is it for?
Any age
Conditions the study is for
Fibromyalgia
What is being tested?
Progressive resistance training program and Educational Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
1 Feb 2016to 25 Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Diagnosis of fibromyalgia according to the criteria of the American College of Rheumatology;
  • Feminine gender;
  • Age between 18 and 65 years;
  • Pain between 3 and 8 cm in the Numerical Pain Scale (END);
  • Have not changed treatment for fibromyalgia in the past three months;
  • Agree to participate in the study and sign the informed consent form.

Who cannot join

  • Cognitive deficit that does not allow the understanding of the evaluation instruments;
  • Other diseases that make it impossible to perform the exercises;
  • Physical activity started or changed in the last three months;
  • Physical therapy in the last six months;
  • In litigation.

About this study

Official title: Evaluation of the Effectiveness of a Progressive Resistance Training Program for Patients With Fibromyalgia: a Randomized Controlled Trial

Patients in the experimental group underwent a progressive resistance training program, performed twice a week for 12 weeks. The charge intensity was progressively increased from 40% to 80% of 1 repetition maximum. The following muscle groups were worked: trunk flexors and extensors, elbow flexors and extensors, knee flexors and extensors, hip abductors and adductors and shoulder abductors. In addition to strength training, the experimental group also conducted a structured education program in one hour class once a week for five weeks. Patients in the control group performed the same education program.

Conditions
Fibromyalgia
Being tested
Progressive resistance training program, Educational Program
Keywords
Fibromyalgia, Pain, Function, Quality of life
Medical subject headings
Fibromyalgia, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Progressive resistance training programOther

    Progressive resistance training program were performed twice a week for 12 weeks. The charge intensity was progressively increased from 40% to 80% of 1 repetition maximum. The following muscle groups were worked: trunk flexors and extensors, elbow flexors and extensors, knee flexors and extensors, hip abductors and adductors and shoulder abductors. In addition to strength training.

  • Educational ProgramOther

    Structured education program were performed during one hour class once a week for five weeks

Study groups in NCT03588208
Study groupRoleWhat they receive
Intervention GroupExperimentalNot described
Receives: Other: Progressive resistance training program; Other: Educational Program
Control GroupActive comparatorNot described
Receives: Other: Educational Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain

    Measured by numerical pain scale

    Measured: Baseline and after 6 and 12 weeks

Secondary outcomes (4)
  1. Change in Health related quality of life

    Measured by Fibromyalgia Impact Questionnaire

    Measured: Baseline and after 6 and 12 weeks

  2. Change in Generic quality of life

    Measured by the Medical Outcome Survey Short Form 36

    Measured: Baseline and after 6 and 12 weeks

  3. Change in Functional capacity

    Measured by the 6-minute Walk Test

    Measured: Baseline and after 6 and 12 weeks

  4. Change in strength

    Measured by the 1 repetition maximum

    Measured: Baseline and after 6 and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2018
  2. Study start1 Feb 2016
  3. Primary completion2 Sep 2017
  4. Study completion25 Mar 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03588208
Sponsor's protocol ID
CEP UNIFESP 482056
Status last verified
Jul 2018
First submitted
4 Jul 2018
Last updated
17 Jul 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Progressive resistance training program and Educational Program in people with Fibromyalgia, run by Federal University of São Paulo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain (time frame: Baseline and after 6 and 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in